Skip to content
10-Q

Quarterly Report

VANSEN PHARMA INC.

0001477932-13-003892

← back to feed
Filed
Aug 19, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2013 · Aug 19, 2013 88.95M sh
Operating Cash Flow Q2 2013 · Jun 30, 2013 −$14.84K
Operating Cash Flow Q2 2013 · Jun 30, 2013 −$231.03K
Operating Cash Flow Q2 2013 · Jun 30, 2012 −$14.5K
Cash And Equivalents Q2 2013 · Jun 30, 2013 $176
Cash And Equivalents Q2 2013 · Dec 31, 2012 $15.02K
Cash And Equivalents Q2 2013 · Jun 30, 2012 $29.27K
Cash And Equivalents Q2 2013 · Dec 31, 2011 $18.77K
Stockholders Equity Q2 2013 · Jun 30, 2013 −$119.35K
Stockholders Equity Q2 2013 · Dec 31, 2012 −$104.46K
Current Liabilities Q2 2013 · Jun 30, 2013 $119.53K
Current Liabilities Q2 2013 · Dec 31, 2012 $119.48K
Total Liabilities Q2 2013 · Jun 30, 2013 $119.53K
Total Liabilities Q2 2013 · Dec 31, 2012 $119.48K
Current Assets Q2 2013 · Jun 30, 2013 $176
Current Assets Q2 2013 · Dec 31, 2012 $15.02K
Total Assets Q2 2013 · Jun 30, 2013 $176
Total Assets Q2 2013 · Dec 31, 2012 $15.02K
Sga Expense Q2 2013 · Jun 30, 2013 $2.78K
Sga Expense Q2 2013 · Jun 30, 2013 $3.14K
Sga Expense Q2 2013 · Jun 30, 2013 $61.9K
Sga Expense Q2 2013 · Jun 30, 2012 $3.95K
Sga Expense Q2 2013 · Jun 30, 2012 $7.33K
Net Income Q2 2013 · Jun 30, 2013 −$18.3K
Net Income Q2 2013 · Jun 30, 2013 −$268.37K
Net Income Q2 2013 · Jun 30, 2012 −$20.85K